Daratumumab plus Bortezomib/Lenalidomide/ Dexamethasone in Patients With Transplant-ineligible or Transplant-deferred Newly Diagnosed Multiple Myeloma: Results of the Phase 3 CEPHEUS Study

被引：0

作者：

Usmani, Saad Z. ^{[1
]}

Facon, Thierry ^{[2
]}

Hungria, Vania ^{[3
]}

Bahlis, Nizar J. ^{[4
]}

Venner, Christopher P. ^{[5
,6
]}

Braunstein, Marc ^{[7
]}

Pour, Ludek ^{[8
]}

Marti, Josep ^{[9
]}

Basu, Supratik ^{[10
,11
]}

Cohen, Yael C. ^{[12
]}

Matsumoto, Morio ^{[13
]}

Suzuki, Kenshi ^{[14
]}

Hulin, Cyrille ^{[15
]}

Grosicki, Sebastian ^{[16
]}

Legiec, Wojciech ^{[17
]}

Beksac, Meral ^{[18
]}

Maiolino, Angelo ^{[19
]}

Liu, Weiping ^{[20
]}

Wang, Jianping ^{[21
]}

Krevvata, Maria ^{[21
]}

Lopez-Masi, Lorena ^{[22
]}

Carey, Jodi ^{[21
]}

Rowe, Melissa ^{[23
]}

Carson, Robin ^{[21
]}

Zweegman, Sonja ^{[24
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[2] Univ Lille, CHU Lille, Serv Malad Sang, Lille, France

[3] Clin Med Sao Germano, Sao Paulo, Brazil

[4] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada

[5] Univ Alberta, Cross Canc Inst, Dept Med Oncol, Edmonton, AB, Canada

[6] Univ British Columbia, BC Canc Vancouver Ctr, Vancouver, BC, Canada

[7] NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USA

[8] Univ Hosp Brno, Brno, Czech Republic

[9] Hosp Univ Mutua Terrassa, Terrassa, Spain

[10] Royal Wolverhampton NHS Trust, Wolverhampton, England

[11] Univ Wolverhampton, CRN West Midlands, NIHR, Wolverhampton, England

[12] Tel Aviv Univ, Fac Med & Hlth Sci, Tel Aviv Sourasky Ichilov Med Ctr, Tel Aviv, Israel

[13] Natl Hosp Org, Dept Hematol, Shibukawa Med Ctr, Gunma, Japan

[14] Japanese Red Cross Med Ctr, Dept Hematol, Tokyo, Japan

[15] Univ Hosp, Dept Hematol, Hop Haut Leveque, Pessac, France

[16] Med Univ Silesian, Sch Publ Hlth, Dept Hematol & Canc Prevent, Katowice, Poland

[17] St John Dukla Oncol Ctr Lublin Land, Dept Hematol & Bone Marrow Transplantat, Lublin, Poland

[18] Istinye Univ, Ankara Liv Hosp, Ankara, Turkiye

[19] Inst Amer Ensino Pesquisa & Inovacao, Rio De Janeiro, Brazil

[20] Janssen Res & Dev, Shanghai, Peoples R China

[21] Janssen Res & Dev LLC, Spring House, PA USA

[22] Janssen Res & Dev LLC, Raritan, NJ USA

[23] Janssen Res & Dev LLC, High Wycombe, Bucks, England

[24] Vrije Univ Amsterdam, Dept Hematol, Canc Ctr Amsterdam, Amsterdam UMC, Amsterdam, Netherlands

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OA-63

引用

页码：S288 / S289

页数：2

共 50 条

[31] Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN [J].

Nooka, Ajay K. ;

Kaufman, Jonathan L. ;

Rodriguez, Cesar ;

Jakubowiak, Andrzej ;

Efebera, Yvonne ;

Reeves, Brandi ;

Wildes, Tanya ;

Holstein, Sarah A. ;

Anderson, Larry D., Jr. ;

Badros, Ashraf ;

Shune, Leyla ;

Chari, Ajai ;

Pei, Huiling ;

Cortoos, Annelore ;

Patel, Sharmila ;

Bartlett, J. Blake ;

Vermeulen, Jessica ;

Lin, Thomas S. ;

Richardson, Paul G. ;

Voorhees, Peter .

BLOOD CANCER JOURNAL, 2022, 12 (04)

[32] Overall survival and progression-free survival by treatment duration with Daratumumab plus Lenalidomide/Dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: phase 3 MAIA study [J].

Moreau, Philippe ;

Facon, Thierry ;

Kumar, Shaji ;

Plesner, Torben ;

Orlowski, Robert Z. ;

Bahlis, Nizar ;

Basu, Supratik ;

Nahi, Hareth ;

Hulin, Cyrille ;

Quach, Hang ;

Goldschmidt, Hartmut ;

O'Dwyer, Michael ;

Perrot, Aurore ;

Venner, Christopher ;

Weisel, Katja ;

Mace, Joseph R. ;

Raje, Noopur ;

Tiab, Mourad ;

Macro, Margaret ;

Frenzel, Laurent ;

Leleu, Xavier ;

Pei, Huiling ;

Tromp, Brenda ;

Delioukina, Maria ;

Usmani, Saad Z. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 :S1-S1

[33] Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial [J].

Leleu, Xavier ;

Hulin, Cyrille ;

Lambert, Jerome ;

Bobin, Arthur ;

Perrot, Aurore ;

Karlin, Lionel ;

Roussel, Murielle ;

Montes, Lydia ;

Cherel, Brieuc ;

Chalopin, Thomas ;

Slama, Borhane ;

Chretien, Marie-Lorraine ;

Laribi, Kamel ;

Dingremont, Claire ;

Roul, Christophe ;

Mariette, Clara ;

Rigaudeau, Sophie ;

Calmettes, Claire ;

Dib, Mamoun ;

Tiab, Mourad ;

Vincent, Laure ;

Delaunay, Jacques ;

Santagostino, Alberto ;

Macro, Margaret ;

Bourgeois, Emmanuelle ;

Orsini-Piocelle, Frederique ;

Gay, Julie ;

Bareau, Benoit ;

Bigot, Noemie ;

Vergez, Francois ;

Lebreton, Pierre ;

Tabrizi, Reza ;

Waultier-Rascalou, Agathe ;

Frenzel, Laurent ;

Le Calloch, Ronan ;

Chalayer, Emilie ;

Braun, Thorsten ;

Lachenal, Florence ;

Corm, Selim ;

Kennel, Celine ;

Belkhir, Rakiba ;

Blade, Jean-Sebastien ;

Joly, Bertrand ;

Richez-Olivier, Valentine ;

Gardeney, Helene ;

Demarquette, Helene ;

Robu-Cretu, Daniela ;

Garderet, Laurent ;

Newinger-Porte, Muriel ;

Kasmi, Amine .

NATURE MEDICINE, 2024, 30 (08) :2235-2241

[34] Belantamab mafodotin, lenalidomide and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: part 1 results of a phase I/II study [J].

Terpos, Evangelos ;

Gavriatopoulou, Maria ;

Ntanasis-Stathopoulos, Ioannis ;

Malandrakis, Panagiotis ;

Fotiou, Despina ;

Migkou, Magdalini ;

Theodorakakou, Foteini ;

Spiliopoulou, Vasiliki ;

Kostopoulos, Ioannis V. ;

Syrigou, Rodanthi-Eleni ;

Eleutherakis-Papaiakovou, Evangelos ;

Gkolfinopoulos, Stavros ;

Tsitsilonis, Ourania E. ;

Kastritis, Efstathios ;

Dimopoulos, Meletios A. .

HAEMATOLOGICA, 2024, 109 (08) :2594-2605

[35] Cost-effectiveness of lenalidomide plus dexamethasone vs bortezomib plus melphalan and prednisone in transplant-ineligible US patients with newly-diagnosed multiple myeloma [J].

Usmani, S. Z. ;

Cavenagh, J. D. ;

Belch, A. R. ;

Hulin, C. ;

Basu, S. ;

White, D. ;

Nooka, A. ;

Ervin-Haynes, A. ;

Yiu, W. ;

Nagarwala, Y. ;

Berger, A. ;

Pelligra, C. G. ;

Guo, S. ;

Binder, G. ;

Gibson, C. J. ;

Facon, T. .

JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (03) :243-258

[36] Efficacy of Daratumumab, Lenalidomide, and Dexamethasone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma and Impaired Renal Function from the Phase 3 Maia Study Based on Lenalidomide Starting Dose [J].

Usmani, Saad Z. ;

Kumar, Shaji ;

Plesner, Torben ;

Orlowski, Robert Z. ;

Moreau, Philippe ;

Bahlis, Nizar J. ;

Basu, Supratik ;

Nahi, Hareth ;

Hulin, Cyrille ;

Quach, Hang ;

Goldschmidt, Hartmut ;

O'Dwyer, Michael E. ;

Perrot, Aurore ;

Venner, Chris P. ;

Weisel, Katja ;

Mace, Joseph R. ;

Raje, Noopur S. ;

Tiab, Mourad ;

Macro, Margaret ;

Frenzel, Laurent ;

Leleu, Xavier ;

Pei, Huiling ;

Van Rampelbergh, Rian ;

Tromp, Brenda ;

Delioukina, Maria ;

Facon, Thierry .

BLOOD, 2021, 138

[37] Final Results of a Phase 2 Study of Modified Lenalidomide, Bortezomib, and Dexamethasone (RVD lite) in Transplant-Ineligible Multiple Myeloma [J].

O'Donnell, Elizabeth ;

Laubach, Jacob ;

Yee, Andrew J. ;

Chen, Tianqi ;

Huff, Carol Ann ;

Basile, Frank G. ;

Wade, Philip ;

Paba-Prada, Claudia ;

Ghobrial, Irene M. ;

Schlossman, Robert ;

Burke, Jill ;

Cynthia, Harrington ;

Lively, Kathleen ;

Lyons, Hannah ;

Munshi, Nikhil ;

Trippa, Lorenzo ;

Anderson, Kenneth C. ;

Richardson, Paul G. ;

Raje, Noopur .

BLOOD, 2017, 130

[38] Real-World Outcomes in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma Treated With Bortezomib/Cyclophosphamide/Dexamethasone and Bortezomib/Lenalidomide/Dexamethasone as Upfront Treatment [J].

Saeed, Nabiha ;

Khan, Zurrya ;

Jehanzeb, Hamzah ;

Shaikh, Taha ;

Shaikh, Usman ;

Adil, Salman N. ;

Madni, Varisha ;

Fatima, Hania ;

Abiha, Umm E. ;

Ali, Natasha .

CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)

[39] Phase 3 Randomized Study of Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Ineligible for Transplant (MAIA) [J].

Facon, Thierry ;

Kumar, Shaji K. ;

Plesner, Torben ;

Orlowski, Robert Z. ;

Moreau, Philippe ;

Bahlis, Nizar ;

Basu, Supratik ;

Nahi, Hareth ;

Hulin, Cyrille ;

Quach, Hang ;

Goldschmidt, Hartmut ;

O'Dwyer, Michael ;

Perrot, Aurore ;

Venner, Christopher P. ;

Weisel, Katja ;

Mace, Joseph R. ;

Ahmadi, Tahamtan ;

Chiu, Christopher ;

Wang, Jianping ;

Van Rampelbergh, Rian ;

Uhlar, Clarissa M. ;

Kobos, Rachel ;

Qi, Ming ;

Usmani, Saad Z. .

BLOOD, 2018, 132

[40] Phase 3 randomized study of Daratumumab plus lenalidomide and Dexamethasone (D-Rd) versus lenalidomide and Dexamethasone (Rd) in patients with newly diagnosed multiple myeloma (NDMM) ineligible for transplant (MAIA) [J].

Weisel, K. ;

Facon, T. ;

Kumar, S. ;

Plesner, T. ;

Orlowski, R. Z. ;

Moreau, P. ;

Bahlis, N. ;

Basu, S. ;

Nahi, H. ;

Hulin, C. ;

Quach, H. ;

Goldschmidt, H. ;

O'Dwyer, M. ;

Perrot, A. ;

Venner, C. P. ;

Mace, J. R. ;

Ahmadi, T. ;

Chiu, C. ;

Wang, J. ;

van Rampelbergh, R. ;

Uhlar, C. M. ;

Kobos, R. ;

Qi, M. ;

Usmani, S. Z. .

ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 :194-194

← 1 2 3 4 5 →